0

Close
 
Upcoming Allied Market Research
2023
Direct-skin Wearable Medical Devices Market

Direct-Skin Wearable Medical Devices Market

by PRODUCT (GLUCOSE MONITORING PATCHES, HEART-MONITORING DEVICES, TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) ELECTRODES DEVICES, OTHERS) and by APPLICATION (METABOLIC DISORDERS, CARDIOVASCULAR DISORDERS, NEUROLOGICAL DISORDERS, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies
Report Code: A04481
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. GLUCOSE MONITORING PATCHES

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. HEART-MONITORING DEVICES

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) ELECTRODES DEVICES

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. OTHERS

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. METABOLIC DISORDERS

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. CARDIOVASCULAR DISORDERS

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. NEUROLOGICAL DISORDERS

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Others

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product

      • 6.2.3. Market Size and Forecast, By Application

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Direct-skin Wearable Medical Devices Market

        • 6.2.5.1. Market Size and Forecast, By Product
        • 6.2.5.2. Market Size and Forecast, By Application

      • 6.2.6. Canada Direct-skin Wearable Medical Devices Market

        • 6.2.6.1. Market Size and Forecast, By Product
        • 6.2.6.2. Market Size and Forecast, By Application

      • 6.2.7. Mexico Direct-skin Wearable Medical Devices Market

        • 6.2.7.1. Market Size and Forecast, By Product
        • 6.2.7.2. Market Size and Forecast, By Application

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product

      • 6.3.3. Market Size and Forecast, By Application

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Direct-skin Wearable Medical Devices Market

        • 6.3.5.1. Market Size and Forecast, By Product
        • 6.3.5.2. Market Size and Forecast, By Application

      • 6.3.6. Germany Direct-skin Wearable Medical Devices Market

        • 6.3.6.1. Market Size and Forecast, By Product
        • 6.3.6.2. Market Size and Forecast, By Application

      • 6.3.7. Italy Direct-skin Wearable Medical Devices Market

        • 6.3.7.1. Market Size and Forecast, By Product
        • 6.3.7.2. Market Size and Forecast, By Application

      • 6.3.8. Spain Direct-skin Wearable Medical Devices Market

        • 6.3.8.1. Market Size and Forecast, By Product
        • 6.3.8.2. Market Size and Forecast, By Application

      • 6.3.9. UK Direct-skin Wearable Medical Devices Market

        • 6.3.9.1. Market Size and Forecast, By Product
        • 6.3.9.2. Market Size and Forecast, By Application

      • 6.3.10. Russia Direct-skin Wearable Medical Devices Market

        • 6.3.10.1. Market Size and Forecast, By Product
        • 6.3.10.2. Market Size and Forecast, By Application

      • 6.3.11. Rest Of Europe Direct-skin Wearable Medical Devices Market

        • 6.3.11.1. Market Size and Forecast, By Product
        • 6.3.11.2. Market Size and Forecast, By Application

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product

      • 6.4.3. Market Size and Forecast, By Application

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Direct-skin Wearable Medical Devices Market

        • 6.4.5.1. Market Size and Forecast, By Product
        • 6.4.5.2. Market Size and Forecast, By Application

      • 6.4.6. Japan Direct-skin Wearable Medical Devices Market

        • 6.4.6.1. Market Size and Forecast, By Product
        • 6.4.6.2. Market Size and Forecast, By Application

      • 6.4.7. India Direct-skin Wearable Medical Devices Market

        • 6.4.7.1. Market Size and Forecast, By Product
        • 6.4.7.2. Market Size and Forecast, By Application

      • 6.4.8. South Korea Direct-skin Wearable Medical Devices Market

        • 6.4.8.1. Market Size and Forecast, By Product
        • 6.4.8.2. Market Size and Forecast, By Application

      • 6.4.9. Australia Direct-skin Wearable Medical Devices Market

        • 6.4.9.1. Market Size and Forecast, By Product
        • 6.4.9.2. Market Size and Forecast, By Application

      • 6.4.10. Thailand Direct-skin Wearable Medical Devices Market

        • 6.4.10.1. Market Size and Forecast, By Product
        • 6.4.10.2. Market Size and Forecast, By Application

      • 6.4.11. Malaysia Direct-skin Wearable Medical Devices Market

        • 6.4.11.1. Market Size and Forecast, By Product
        • 6.4.11.2. Market Size and Forecast, By Application

      • 6.4.12. Indonesia Direct-skin Wearable Medical Devices Market

        • 6.4.12.1. Market Size and Forecast, By Product
        • 6.4.12.2. Market Size and Forecast, By Application

      • 6.4.13. Rest of Asia Pacific Direct-skin Wearable Medical Devices Market

        • 6.4.13.1. Market Size and Forecast, By Product
        • 6.4.13.2. Market Size and Forecast, By Application

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product

      • 6.5.3. Market Size and Forecast, By Application

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Direct-skin Wearable Medical Devices Market

        • 6.5.5.1. Market Size and Forecast, By Product
        • 6.5.5.2. Market Size and Forecast, By Application

      • 6.5.6. South Africa Direct-skin Wearable Medical Devices Market

        • 6.5.6.1. Market Size and Forecast, By Product
        • 6.5.6.2. Market Size and Forecast, By Application

      • 6.5.7. Saudi Arabia Direct-skin Wearable Medical Devices Market

        • 6.5.7.1. Market Size and Forecast, By Product
        • 6.5.7.2. Market Size and Forecast, By Application

      • 6.5.8. UAE Direct-skin Wearable Medical Devices Market

        • 6.5.8.1. Market Size and Forecast, By Product
        • 6.5.8.2. Market Size and Forecast, By Application

      • 6.5.9. Argentina Direct-skin Wearable Medical Devices Market

        • 6.5.9.1. Market Size and Forecast, By Product
        • 6.5.9.2. Market Size and Forecast, By Application

      • 6.5.10. Rest of LAMEA Direct-skin Wearable Medical Devices Market

        • 6.5.10.1. Market Size and Forecast, By Product
        • 6.5.10.2. Market Size and Forecast, By Application

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning,2022

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. MEDTRONIC, PLC

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. MACTAC, LLC

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. ABBOTT

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. L'ORÉAL S.A.

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. THE TENS + COMPANY

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Company 6

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Company 7

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Company 8

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Company 9

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Company 10

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR GLUCOSE MONITORING PATCHES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR HEART-MONITORING DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) ELECTRODES DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR METABOLIC DISORDERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR CARDIOVASCULAR DISORDERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR NEUROLOGICAL DISORDERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. NORTH AMERICA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 15. U.S. DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 16. U.S. DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 17. CANADA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 18. CANADA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 19. MEXICO DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 20. MEXICO DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 21. EUROPE DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. EUROPE DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 23. EUROPE DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 24. FRANCE DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 25. FRANCE DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 26. GERMANY DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 27. GERMANY DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 28. ITALY DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 29. ITALY DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 30. SPAIN DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 31. SPAIN DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 32. UK DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 33. UK DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 34. RUSSIA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 35. RUSSIA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 36. REST OF EUROPE DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 37. REST OF EUROPE DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 38. ASIA-PACIFIC DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 39. ASIA-PACIFIC DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 40. ASIA-PACIFIC DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 41. CHINA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 42. CHINA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 43. JAPAN DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 44. JAPAN DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 45. INDIA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 46. INDIA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 47. SOUTH KOREA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 48. SOUTH KOREA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 49. AUSTRALIA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 50. AUSTRALIA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 51. THAILAND DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 52. THAILAND DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 53. MALAYSIA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 54. MALAYSIA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 55. INDONESIA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 56. INDONESIA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 57. REST OF ASIA PACIFIC DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 58. REST OF ASIA PACIFIC DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 59. LAMEA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 60. LAMEA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 61. LAMEA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 62. BRAZIL DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 63. BRAZIL DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 64. SOUTH AFRICA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 65. SOUTH AFRICA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 66. SAUDI ARABIA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 67. SAUDI ARABIA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 68. UAE DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 69. UAE DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 70. ARGENTINA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 71. ARGENTINA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 72. REST OF LAMEA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 73. REST OF LAMEA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 74. MEDTRONIC, PLC: KEY EXECUTIVES
  • TABLE 75. MEDTRONIC, PLC: COMPANY SNAPSHOT
  • TABLE 76. MEDTRONIC, PLC: OPERATING SEGMENTS
  • TABLE 77. MEDTRONIC, PLC: PRODUCT PORTFOLIO
  • TABLE 78. MEDTRONIC, PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 79. MACTAC, LLC: KEY EXECUTIVES
  • TABLE 80. MACTAC, LLC: COMPANY SNAPSHOT
  • TABLE 81. MACTAC, LLC: OPERATING SEGMENTS
  • TABLE 82. MACTAC, LLC: PRODUCT PORTFOLIO
  • TABLE 83. MACTAC, LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 84. ABBOTT: KEY EXECUTIVES
  • TABLE 85. ABBOTT: COMPANY SNAPSHOT
  • TABLE 86. ABBOTT: OPERATING SEGMENTS
  • TABLE 87. ABBOTT: PRODUCT PORTFOLIO
  • TABLE 88. ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 89. L'ORÉAL S.A.: KEY EXECUTIVES
  • TABLE 90. L'ORÉAL S.A.: COMPANY SNAPSHOT
  • TABLE 91. L'ORÉAL S.A.: OPERATING SEGMENTS
  • TABLE 92. L'ORÉAL S.A.: PRODUCT PORTFOLIO
  • TABLE 93. L'ORÉAL S.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 94. THE TENS + COMPANY: KEY EXECUTIVES
  • TABLE 95. THE TENS + COMPANY: COMPANY SNAPSHOT
  • TABLE 96. THE TENS + COMPANY: OPERATING SEGMENTS
  • TABLE 97. THE TENS + COMPANY: PRODUCT PORTFOLIO
  • TABLE 98. THE TENS + COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 99. COMPANY 6: KEY EXECUTIVES
  • TABLE 100. COMPANY 6: COMPANY SNAPSHOT
  • TABLE 101. COMPANY 6: OPERATING SEGMENTS
  • TABLE 102. COMPANY 6: PRODUCT PORTFOLIO
  • TABLE 103. COMPANY 6: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 104. COMPANY 7: KEY EXECUTIVES
  • TABLE 105. COMPANY 7: COMPANY SNAPSHOT
  • TABLE 106. COMPANY 7: OPERATING SEGMENTS
  • TABLE 107. COMPANY 7: PRODUCT PORTFOLIO
  • TABLE 108. COMPANY 7: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 109. COMPANY 8: KEY EXECUTIVES
  • TABLE 110. COMPANY 8: COMPANY SNAPSHOT
  • TABLE 111. COMPANY 8: OPERATING SEGMENTS
  • TABLE 112. COMPANY 8: PRODUCT PORTFOLIO
  • TABLE 113. COMPANY 8: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 114. COMPANY 9: KEY EXECUTIVES
  • TABLE 115. COMPANY 9: COMPANY SNAPSHOT
  • TABLE 116. COMPANY 9: OPERATING SEGMENTS
  • TABLE 117. COMPANY 9: PRODUCT PORTFOLIO
  • TABLE 118. COMPANY 9: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119. COMPANY 10: KEY EXECUTIVES
  • TABLE 120. COMPANY 10: COMPANY SNAPSHOT
  • TABLE 121. COMPANY 10: OPERATING SEGMENTS
  • TABLE 122. COMPANY 10: PRODUCT PORTFOLIO
  • TABLE 123. COMPANY 10: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET
  • FIGURE 3. SEGMENTATION DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALDIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET
  • FIGURE 11. DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR GLUCOSE MONITORING PATCHES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR HEART-MONITORING DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) ELECTRODES DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 17. DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR METABOLIC DISORDERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR CARDIOVASCULAR DISORDERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 25. COMPETITIVE DASHBOARD
  • FIGURE 26. COMPETITIVE HEATMAP: DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET
  • FIGURE 27. Top player positioning, 2022
  • FIGURE 28. MEDTRONIC, PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 29. MEDTRONIC, PLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 30. MEDTRONIC, PLC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 31. MACTAC, LLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 32. MACTAC, LLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 33. MACTAC, LLC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 34. ABBOTT: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 35. ABBOTT: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 36. ABBOTT: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 37. L'ORÉAL S.A.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 38. L'ORÉAL S.A.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 39. L'ORÉAL S.A.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 40. THE TENS + COMPANY: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 41. THE TENS + COMPANY: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 42. THE TENS + COMPANY: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 43. COMPANY 6: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 44. COMPANY 6: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 45. COMPANY 6: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 46. COMPANY 7: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 47. COMPANY 7: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 48. COMPANY 7: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 49. COMPANY 8: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. COMPANY 8: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 51. COMPANY 8: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 52. COMPANY 9: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. COMPANY 9: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 54. COMPANY 9: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 55. COMPANY 10: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. COMPANY 10: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 57. COMPANY 10: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Direct-skin Wearable Medical Devices Market

Start reading.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers